| 23/531 |
Usage of Ruxolitinib |
| 23/530 |
Admissions, Discharges & Hospital Beds 2018 - 2023 |
| 23/529 |
Midwifery Job Titles |
| 23/526 |
Severe Dental Distress & Tooth Decay 2019 & 2023 |
| 23/522 |
Ultrasound Machines |
| 23/521 |
Organ Transplant Training |
| 23/520 |
Organ Transplantation Collaborating with Chinese Hospitals or Universities 01.08.2018 - 01.08.2023 |
| 23/519 |
Cannulas, Bed Occupancy, Attendances & Clinical Waste |
| 23/518 |
Maternity Complaints By Ethnicity 2018 - 2022 |
| 23/517 |
Homecare Medicine Services Providers |
| 23/516 |
Agency Nursing & International Nursing Recruitment |
| 23/515 |
Remote Monitoring Services for Virtual Wards |
| 23/514 |
Covid-19 Policy & Timeframe for Routine Vascular Assessment May 2021 |
| 23/513 |
ESHT Staff Gender Identity Training |
| 23/512 |
Maternity Training |
| 23/511 |
Agency Nurse Usage & Spend |
| 23/510 |
Antenatal & Newborn Screening Team Provision |
| 23/509 |
Radiology & Ultrasound Dept Band 7 - Band 9 AHPs |
| 23/507 |
Agency Spend 01.01.2023 - 30.06.2023 |
| 23/506 |
Pulmonary Rehabilitation |
